|
SRGAP2 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.342900E-03 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.681700E-03 |
| Normal-vs-AfricanAmerican |
7.902900E-03 |
| Normal-vs-Asian |
1.108040E-01 |
| Caucasian-vs-AfricanAmerican |
5.063400E-01 |
| Caucasian-vs-Asian |
7.274800E-01 |
| AfricanAmerican-vs-Asian |
9.831400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.032320E-02 |
| Normal-vs-Female |
2.740200E-03 |
| Male-vs-Female |
5.915800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.037500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.098100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.443160E-03 |
| Normal-vs-Age(81-100Yrs) |
1.951040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.768200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.185600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.933400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.696800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.949200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
4.679900E-03 |
| Normal-vs-Pheochromocytoma |
7.017300E-03 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.242700E-03 |
| Paraganglioma-vs-Pheochromocytoma |
8.131800E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.108000E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
1.484450E-01 |
|
|
